TESAŘOVÁ, Lenka, Pavel ŠIMARA, Stanislav STEJSKAL and Irena KRONTORÁD KOUTNÁ. Haematopoietic developmental potential of human pluripotent stem cell lines. Folia biologica. Praha: Univerzita Karlova, 2014, vol. 60, No 1, p. 90-94. ISSN 0015-5500.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Haematopoietic developmental potential of human pluripotent stem cell lines
Authors TESAŘOVÁ, Lenka (203 Czech Republic, belonging to the institution), Pavel ŠIMARA (203 Czech Republic, belonging to the institution), Stanislav STEJSKAL (203 Czech Republic, belonging to the institution) and Irena KRONTORÁD KOUTNÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition Folia biologica, Praha, Univerzita Karlova, 2014, 0015-5500.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.000
RIV identification code RIV/00216224:14330/14:00073970
Organization unit Faculty of Informatics
UT WoS 000343275800015
Keywords (in Czech) lidské pluripotentní kmenové buňky; hematopoetický vývoj; embryoidní tělíska; CD34+ buňky
Keywords in English human pluripotent stem cells; hematopoietic development; embryoid bodies; CD34+ cells
Tags cbia-web
Changed by Changed by: Mgr. Pavel Šimara, Ph.D., učo 67594. Changed: 2/3/2018 10:06.
Abstract
The generation of hematopoietic progenitors from human pluripotent stem cells (hPSCs) presents great promise for cell-replacement therapies. However, current protocols for hematopoietic differentiation of hPSCs suffer from low efficiency and functional defects in the derived cells. The technology is also limited by variable ability of hPSC lines to generate blood cells in vitro. To address this issue, methodologies for hematopoietic differentiation in feeder-free conditions were applied to available human embryonic stem cell (hESC) and human induced pluripotent stem cell (hiPSC) lines in this study. It was found that these cell lines did not generate hematopoietic progenitors in such an extent as H1 and H9 hESC lines used for this purpose in the vast majority of relevant studies. These results suggest that for clinical application of blood cells derived from hPSCs, possibly from autologous hiPSCs, it is necessary to overcome the variability in the hematopoietic developmental potential of individual hPSC lines.
Links
CZ.1.07/2.3.00/30.0030, interní kód MUName: Rozvoj lidských zdrojů pro oblast buněčné biologie
Investor: Ministry of Education, Youth and Sports of the CR, 2.3 Human resources in research and development
GBP302/12/G157, research and development projectName: Dynamika a organizace chromosomů během buněčného cyklu a při diferenciaci v normě a patologii
Investor: Czech Science Foundation
PrintDisplayed: 23/8/2024 07:58